LATEST

AP: SEC Dismisses Rumours On Viral Local Body Polls Schedule On SM✦China’s CXMT to favour domestic suppliers in US$5.2b memory-chip capacity push: source✦North Korean mines behind DMZ blast that injured 2 South Koreans, Seoul says✦UK Needs 'Sovereign Level of Compute,' AI Minister Says✦Why Citi is betting on China’s 30-year bonds as US Treasury yields climb✦

Lilly's Foundayo Tops Oral Semaglutide In New Diabetes Analysis

(RTTNews) - Eli Lilly and Company (LLY) reported that Foundayo 17.2 mg was associated with greater weight loss and bette...

By Dhallo News · September 29, 2026 at 2:14 PM IST

(RTTNews) - Eli Lilly and Company (LLY) reported that Foundayo 17.2 mg was associated with greater weight loss and better blood sugar control than oral semaglutide 25 mg in adults with type 2 diabetes, based on a new indirect treatment comparison.

SOURCE: Nasdaq

ORIGINAL REPORT: Click here

DHALLO EDITORIAL STATUS: Aggregated & reviewed

Have feedback on this article?Report error or suggestion

Read More from Markets

Penny stock under 10 rupees jumps 5% despite weak trends on Dalal Street; here's latest company update

The stock rose around 5% to its day's high of ₹1.75 per share on BSE. It was als...

Read Article »

Lux Capital in Talks to Join Onodrim Round at Unicorn Valuation

Lux Capital, a backer of Anduril Industries Inc. and Hadrian Automation Inc., is...

Read Article »

Saudi Arabia Restores Key Oil Pipeline as Hormuz Talks Stall

Horizons Middle East & Africa is your daily spotlight on one of the world's fast...

Read Article »

Return to Front Page

5 minutes. The news that matters.

Get the most important stories of the day, without having to browse hundreds of articles.